Cite
HARVARD Citation
Pariente, B. et al. (2018). Editorial: paradoxical skin lesions during anti‐TNF treatment—an additional argument to consider new biologics as first line therapy in inflammatory bowel disease. Alimentary pharmacology & therapeutics. 48 (6), pp. 683-684. [Online].